March #57 : ddIDay - by James Learned

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Newsletters
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join
Username:
Password:

Back to home » Archives » POZ Magazine issues




Table of Contents

Woman on the Verge

The River Runs Through It

The Jelly Revolution

Let's Dance

Publisher's Letter

Mailbox

Catching Up With...

Call The Cops

Say What?

Big Bro

Chew the Stat

NEG/POS

Trade Route To Riot

Bookmark This

Nana’s Natural Remedy

Underground Railroad

Milestones

The Body Politic

High Crimes

Low Blows

Trip The Light Magnificent

Relatively Speaking

A Tricky Combination

Beat The Blues

Down But Not Out

Comfort Zone

Tendergroin District

The Matrix

Beyond Eradication

Herb Of The Month

ddIDay

3.29.89: Fine Toon



Most Popular Lessons

The HIV Life Cycle

Shingles

Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV


email print

March 2000

ddIDay

by James Learned

Nausea, vomiting, abdominal pain: Too many HIVers accept these as business as usual—a bad idea. If you’re on ddI (Videx) when one of these afflictions strikes, call your doctor, pronto. If a blood test finds high levels of the enzymes amylase or lipase, you may have pancreatitis, a sometimes-fatal inflammation of the pancreas (a gland that regulates blood sugar and produces digestive enzymes). Four recent deaths from pancreatitis have forced ddI manufacturer Bristol-Myers Squibb (BMS) to catapult its previous package-insert warning from fine print to boldface in a black box.

Two deaths occurred in a trial studying a combo of ddI, d4T (Zerit), Crixivan (indinavir) and hydroxyurea. Separately,  two HIVers on ddI, d4T and a protease inhibitor also died of pancreatitis. Note well: All four had CD4 counts above 500 and viral loads below 200. Meanwhile, studies have shown that d4T, ddC (Hivid), AZT (Retrovir), ritonavir (Norvir) and nelfinavir (Viracept) can all spark pancreatitis, though at much lower rates than does ddI.

BMS urges docs who suspect pancreatitis to take their patients off ddI immediately—and suspend d4T and hydroxyurea, if also being taken. Folks at greatest risk for pancreatitis should think twice before starting ddI and at least monitor enzyme levels closely once on it. These include people using meds such as pentamidine or those with heavy alcohol use, obesity, kidney problems, gallstones or high triglycerides (a concern for many HAART-takers).

Pancreatitis has been found to generate an assault of free radicals (tissue-damaging molecules) that can be countered by antioxidant nutrients. So nutrition-savvy docs recommend that those on risky meds add selenium, vitamins C and E, alpha-lipoic acid and N-acetyl-cysteine (NAC) to their regimen as a preventive. Some small German studies have found intravenous selenium to be highly effective in treating acute pancreatitis.




[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Poll
Have you ever been diagnosed with diabetes or pre-diabetes?
Yes
No

Survey
Pop Watch

more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2014 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.